Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Pharmacology

13.11.2024

Pharmacogenomics: how genetic inheritance modulates the effects of drugs

09.10.2024

Reducing the use of animals in toxicological research with data science and artificial intelligence

29.11.2023

Animal experimentation in toxicology for the 21st century: needed or outdated?

29.08.2023

The eTRANSAFE project finishes with a huge database and a drug safety predictive tool

31.07.2023

Advancing in the development of more efficient drugs

05.01.2023

NoctuRNA Therapeutics: a spin-off for broad-spectrum antivirals

27.12.2022

NOVIRUSES2BRAIN: A project to develop «smugglers» capable of crossing physiological barriers to attack viruses

29.11.2021

A strategic agreement to accelerate the development of new drugs

cannabis plant and pills
23.07.2021

David Andreu (DCEXS-UPF): “Cannabis co-administered with the drug we have developed would offer analgesia without cognitive side effects”

22.06.2021

Sílvia Alemany (ISGlobal): “I think the use of paracetamol during pregnancy should be monitored more tightly”

17.02.2021

A clinical trial to verify the effectiveness of a new drug against COVID-19

29.01.2021

Ivermectin could reduce viral transmission of COVID-19

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2025 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

*Required field

Field is not valid
You have to authorize data treatment

At any time, you can exercise the rights of access, rectification, opposition, portability, limitation to treatment and deletion of the data subject to treatment by clicking on the links "Update data" and "Unsubscribe", sending a letter indicating the right exercised to the postal address indicated at the bottom or to the following email address ellipse@prbb.org